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Abstract
Hereditary non-polyposis colorectal carcinoma (HNPCC) 
is an autosomal dominant disorder associated with 
colorectal and endometrial cancer and a range of other 
tumor types. Germline mutations in the DNA mismatch 
repair (MMR) genes, particularly MLH1,  MSH2, and 
MSH6 , underlie this disorder. The vast majority of 
these HNPCC-associated mutations have been proven, 
or assumed, given the family history of cancer, to be 
transmitted through several generations. To the best 
of our knowledge, only a single case of a de novo  
germline MMR gene mutation (in MSH2 ) has been 
reported till now. Here, we report a patient with a de 
novo  mutation in MLH1 . We identified a MLH1 Q701X 
truncating mutation in the blood lymphocytes of a male 
who had been diagnosed with rectal cancer at the age 
of 35. His family history of cancer was negative for the 
first- and second-degree relatives. The mutation could 
not be detected in the patient’s parents and sibling and 
paternity was confirmed with a set of highly polymorphic 
markers. Non-penetrance and small family size is 
the common explanation of verified negative family 
histories of cancer in patients with a germline MMR gene 
mutation. However, in addition to some cases explained 
by non-paternity, de novo  germline mutations should 
be considered as a possible explanation as well. As 
guidelines that stress not to restrict MMR gene mutation 
testing to patients with a positive family history are more 
widely introduced, more cases of de novo  MMR gene 
germline mutations may be revealed.
© 2006 The WJG Press. All rights reserved.
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Hereditary non-polyposis colorectal carcinoma (HNPCC) 
is a genetic disorder caused by germline mutations in DNA 
mismatch repair (MMR) genes, especially MLH1, MSH2 
and MSH6. HNPCC is characterized clinically by the early-
onset colorectal and endometrial cancer as well as a range 
of  other tumor types. In contrast to familial adenomatous 
polyposis (FAP), HNPCC lacks an easily recognizable 
clinical phenotype in individual patients. The original and 
revised Amsterdam criteria (AC and AC II) introduced 
to clinically define HNPCC therefore include specific 
characteristics of  the family history that should be met[1,2]. 
However, it has become clear that HNPCC patients may 
have a negative family history. Small family sizes and less 
than 100% penetrance of  the germline mutations involved 
are its most common explanation. Here, we report the rare 
phenomenon of  a de novo germline MMR gene mutation 
as the cause of  a negative family history in a patient with 
hereditary non-polyposis colorectal carcinoma.
CASE REPORT
A 35-year-old male had been referred to our department 
for genetic testing and counseling because he had 
very recently been diagnosed with a T4N0M0 rectal 
adenocarcinoma. Family history of  cancer was negative for 
the first- and second-degree relatives of  the patient. The 
patient’s mother, father, and sibling (aged 60, 61, and 38 
years, respectively) were healthy.
 As part of  an ongoing study on the genetics of  
colorectal cancer, testing for tumor microsatellite instability 
(MSI), tumor immunohistochemistry for the MLH1, 
MSH2 and MSH6 proteins as well as mutation analysis of  
MLH1, MSH2 and MSH6 are offered to all the patients 
with colorectal cancer diagnosed before the age of  50 
who are referred to our department for genetic testing and 
counseling.
DNA was extracted from formalin-fixed and paraffin-
embedded tumor and non-tumor tissues as described 
previously[3]. Subsequent MSI analysis was performed 
using criteria and primers as described in the Bethesda 
www.wjgnet.com
guidelines[4]. PCR products were analyzed on 60 g/L 
denaturing polyacrylamide gels with an LKB ALF DNA 
sequencer. For data analysis, the DNA fragment analyzer 
(Pharmacia) was used.
 Immunohistochemistry for MLH1, MSH2, and 
MSH6 protein expression was carried out as described 
previously [5]. Protein expression in normal t issue 
surrounding the cancer served as internal control.
Mutation analysis of  the MLH1 and MSH2 genes in 
DNA obtained from peripheral blood lymphocytes was 
carried out using denaturing gradient gel electrophoresis 
(DGGE), followed in case of  aberrant patterns by direct 
sequencing of  independently amplified PCR products as 
previously described[6,7]. To investigate paternity, a panel 
of  six highly polymorphic markers was analyzed with 
PCR using markers D1S162, D2S202, D4S174, D11S875, 
D17S250, and IL2-RB in the patient and his parents. 
PCR products were analyzed on 60 g/L denaturing 
polyacrylamide gels with an LKB ALF DNA sequencer. 
For data analysis, the DNA fragment analyzer (Pharmacia) 
was used.
 The tumor of  the patient revealed microsatellite 
instability (MSI-H), as well as loss of  immunohistochemical 
staining for the MLH1 protein with a positive internal 
control. Mutation analysis revealed a C to T substitution 
at nucleotide 2 101 in exon 18 of  the MLH1 gene, leading 
to an early stop codon (Gln701Stop). Neither the father 
nor the mother carried the mutation identified in their 
son (Figures 1 and 2). All six tested markers were in 
concordance with paternity (likelihood: >99.9%) (Figure 3) 
DISCUSSION
Although the Q701X MLH1 mutation has not been 
reported before in either the Human Gene Mutation 
Database (HGMD) and the ICG-HNPCC database, 
we have no reason to doubt its pathogenicity given its 
truncating nature and the findings of  MSI-H and loss of  
staining for the MLH1 protein in the patient’s tumor[8,9].
De novo germline mutations of  the MMR genes in 
HNPCC are rare. To the best of  our knowledge, only 
one single case, involving MSH2, has been reported so 
far[10]. We have identified a de novo germline mutation in 
the MLH1 gene. The classification “germline” mutation 
is generally used in oncogenetics to distinguish mutations 
that can be transmitted to the offspring from the somatic 
mutations occurring locally in tissues and which may lead 
to local tumor development. For practical purposes, we 
therefore used the “germline” label. Strictly speaking, 
mutations classified as de novo germline mutations should 
refer to a single mutation occurring in a single germcell. 
Clinically, these often cannot be distinguished from an 
early postzygotic mutational event in the patient, or from 
germline mosaicism or somatic mosaicism extending to 
extra-gonadal tissues in the parents. We did not have the 
opportunity to test multiple tissues in our patient or his 
parents for the mutation. The patient’s single sibling was 
offered mutation analysis and was shown to carry the 
wild-type MLH1 alleles. Therefore, we lack proof  of  the 
germline nature of  the de novo mutation reported by us and 
the same is true for the MSH2 case published earlier by 
Kraus et al [10]. In clinical practice, this lack of  proof  does 
not lead to any obvious problems. One will simply discuss 
with the patient the fact that his or her siblings have a, 
probably small, risk to carry the mutation as well and one 
will offer to test them for it.
 Non-penetrance and small family size is the common 
explanation of  verified negative family histories of  cancer 
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Figure 1  Denaturing gradient gel electrophoresis (DGGE) analysis of exon 18 of 
MLH1 gene. Lanes 1 and 2: Father and mother, respectively; lane 3: index patient.
Figure 3  Paterni ty 
t e s t  u s i n g  s i x 
h i g h l y  i n f o r m a t i v e 
microsatellites. a: The 
index patient; b: his 
father; c: his mother.
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Figure 2  DNA sequence analysis of exon 18 of MLH1 gene. (a) A control sample 
without mutation, (b) the index patient showing a C to T substitution of base 2 101 
leading to Gln701Stop.
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in patients with a germline MMR gene mutation. However, 
in addition to some cases due to non-paternity, de novo 
“germline” mutations should be considered as a possible 
explanation as well. The percentage of  these mutations 
in HNPCC remains to be established. As guidelines (e.g., 
the Bethesda guidelines)[4] that stress not to limit MMR 
gene mutation testing to patients with a positive family 
history are more widely introduced, more cases of  de novo 
“germline” MMR mutations are yet to be revealed.
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